-
1
-
-
72249092928
-
Recent advances in understanding leptin signaling and leptin resistance
-
Morris D.L., Rui L. Recent advances in understanding leptin signaling and leptin resistance. Am. J. Physiol. Endocrinol. Metab. 2009, 297:E1247-E1259.
-
(2009)
Am. J. Physiol. Endocrinol. Metab.
, vol.297
-
-
Morris, D.L.1
Rui, L.2
-
2
-
-
77955921088
-
The growth hormone receptor: mechanism of activation and clinical implications
-
Brooks A.J., Waters M.J. The growth hormone receptor: mechanism of activation and clinical implications. Nat. Rev. Endocrinol. 2010, 6:515-525.
-
(2010)
Nat. Rev. Endocrinol.
, vol.6
, pp. 515-525
-
-
Brooks, A.J.1
Waters, M.J.2
-
3
-
-
77950356668
-
Narrative review: thrombocytosis, polycythemia vera, and JAK2 mutations: the phenotypic mimicry of chronic myeloproliferation
-
Spivak J.L. Narrative review: thrombocytosis, polycythemia vera, and JAK2 mutations: the phenotypic mimicry of chronic myeloproliferation. Ann. Intern. Med. 2010, 152:300-306.
-
(2010)
Ann. Intern. Med.
, vol.152
, pp. 300-306
-
-
Spivak, J.L.1
-
4
-
-
77955911496
-
Molecular basis of cytokine receptor activation
-
Lopez A.F., Hercus T.R., Ekert P., Littler D.R., Guthridge M., Thomas D., Ramshaw H.S., Stomski F., Perugini M., D'Andrea R., Grimbaldeston M., Parker M.W. Molecular basis of cytokine receptor activation. IUBMB Life 2010, 62:509-518.
-
(2010)
IUBMB Life
, vol.62
, pp. 509-518
-
-
Lopez, A.F.1
Hercus, T.R.2
Ekert, P.3
Littler, D.R.4
Guthridge, M.5
Thomas, D.6
Ramshaw, H.S.7
Stomski, F.8
Perugini, M.9
D'Andrea, R.10
Grimbaldeston, M.11
Parker, M.W.12
-
5
-
-
70350440089
-
JAK redux: a second look at the regulation and role of JAKs in the heart
-
Kurdi M., Booz G.W. JAK redux: a second look at the regulation and role of JAKs in the heart. Am. J. Physiol. Heart Circ. Physiol. 2009, 297:H1545-H1556.
-
(2009)
Am. J. Physiol. Heart Circ. Physiol.
, vol.297
-
-
Kurdi, M.1
Booz, G.W.2
-
6
-
-
78650664262
-
The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors
-
Baskin R., Majumder A., Sayeski P.P. The recent medicinal chemistry development of Jak2 tyrosine kinase small molecule inhibitors. Curr. Med. Chem. 2010, 17:4551-4558.
-
(2010)
Curr. Med. Chem.
, vol.17
, pp. 4551-4558
-
-
Baskin, R.1
Majumder, A.2
Sayeski, P.P.3
-
7
-
-
79955675817
-
JAK2 Translocations in hematological malignancies: review of the literature
-
Ho K., Valdez F., Garcia R., Tirado C.A. JAK2 Translocations in hematological malignancies: review of the literature. J. Assoc. Genet. Technol. 2010, 36:107-109.
-
(2010)
J. Assoc. Genet. Technol.
, vol.36
, pp. 107-109
-
-
Ho, K.1
Valdez, F.2
Garcia, R.3
Tirado, C.A.4
-
8
-
-
77953529304
-
JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms
-
Oh S.T., Gotlib J. JAK2 V617F and beyond: role of genetics and aberrant signaling in the pathogenesis of myeloproliferative neoplasms. Expert. Rev. Hematol. 2010, 3:323-337.
-
(2010)
Expert. Rev. Hematol.
, vol.3
, pp. 323-337
-
-
Oh, S.T.1
Gotlib, J.2
-
9
-
-
79955644381
-
JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations
-
Pardanani A., Vannucchi A.M., Passamonti F., Cervantes F., Barbui T., Tefferi A. JAK inhibitor therapy for myelofibrosis: critical assessment of value and limitations. Leukemia 2010.
-
(2010)
Leukemia
-
-
Pardanani, A.1
Vannucchi, A.M.2
Passamonti, F.3
Cervantes, F.4
Barbui, T.5
Tefferi, A.6
-
10
-
-
79955655143
-
JAK2 inhibitors: what's the true therapeutic potential?
-
Santos F.P., Verstovsek S. JAK2 inhibitors: what's the true therapeutic potential?. Blood Rev. 2010.
-
(2010)
Blood Rev.
-
-
Santos, F.P.1
Verstovsek, S.2
-
11
-
-
70449520449
-
Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics
-
Tefferi A., Skoda R., Vardiman J.W. Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics. Nat. Rev. Clin. Oncol. 2009, 6:627-637.
-
(2009)
Nat. Rev. Clin. Oncol.
, vol.6
, pp. 627-637
-
-
Tefferi, A.1
Skoda, R.2
Vardiman, J.W.3
-
12
-
-
77954581139
-
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
-
Tefferi A. Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. Leukemia 2010, 24:1128-1138.
-
(2010)
Leukemia
, vol.24
, pp. 1128-1138
-
-
Tefferi, A.1
-
13
-
-
79953119707
-
JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon
-
Mahfouz R.A., Hoteit R., Salem Z., Bazarbachi A., Mugharbel A., Farhat F., Ziyadeh A., Ibrahim A., Taher A. JAK2 V617F gene mutation in the laboratory work-up of myeloproliferative disorders: experience of a major referral center in Lebanon. Genet. Test. Mol. Biomarkers 2011, 5:67.
-
(2011)
Genet. Test. Mol. Biomarkers
, vol.5
, pp. 67
-
-
Mahfouz, R.A.1
Hoteit, R.2
Salem, Z.3
Bazarbachi, A.4
Mugharbel, A.5
Farhat, F.6
Ziyadeh, A.7
Ibrahim, A.8
Taher, A.9
-
14
-
-
0031766632
-
Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors
-
Gong T.W., Meyer D.J., Liao J., Hodge C.L., Campbell G.S., Wang X., Billestrup N., Carter-Su C., Schwartz J. Regulation of glucose transport and c-fos and egr-1 expression in cells with mutated or endogenous growth hormone receptors. Endocrinology 1998, 139:1863-1871.
-
(1998)
Endocrinology
, vol.139
, pp. 1863-1871
-
-
Gong, T.W.1
Meyer, D.J.2
Liao, J.3
Hodge, C.L.4
Campbell, G.S.5
Wang, X.6
Billestrup, N.7
Carter-Su, C.8
Schwartz, J.9
-
15
-
-
0032537942
-
Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action
-
Yokota I., Hayashi H., Matsuda J., Saijo T., Naito E., Ito M., Ebina Y., Kuroda Y. Effect of growth hormone on the translocation of GLUT4 and its relation to insulin-like and anti-insulin action. Biochim. Biophys. Acta 1998, 1404:451-456.
-
(1998)
Biochim. Biophys. Acta
, vol.1404
, pp. 451-456
-
-
Yokota, I.1
Hayashi, H.2
Matsuda, J.3
Saijo, T.4
Naito, E.5
Ito, M.6
Ebina, Y.7
Kuroda, Y.8
-
16
-
-
70349694075
-
Glucose transporters in sex steroid hormone related cancer
-
Nualart F., Los Angeles G.M., Medina R.A., Owen G.I. Glucose transporters in sex steroid hormone related cancer. Curr. Vasc. Pharmacol. 2009, 7:534-548.
-
(2009)
Curr. Vasc. Pharmacol.
, vol.7
, pp. 534-548
-
-
Nualart, F.1
Los Angeles, G.M.2
Medina, R.A.3
Owen, G.I.4
-
18
-
-
1242272759
-
The sodium/glucose cotransport family SLC5
-
Wright E.M., Turk E. The sodium/glucose cotransport family SLC5. Pflugers Arch. 2004, 447:510-518.
-
(2004)
Pflugers Arch.
, vol.447
, pp. 510-518
-
-
Wright, E.M.1
Turk, E.2
-
19
-
-
53949106060
-
Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival
-
Casneuf V.F., Fonteyne P., Van Damme N., Pauwels P., de Hemptinne B., De Vos M., Van de W.C., Peeters M. Expression of SGLT1, Bcl-2 and p53 in primary pancreatic cancer related to survival. Cancer Invest. 2008, 26:852-859.
-
(2008)
Cancer Invest.
, vol.26
, pp. 852-859
-
-
Casneuf, V.F.1
Fonteyne, P.2
Van Damme, N.3
Pauwels, P.4
de Hemptinne, B.5
De Vos, M.6
Van de, W.C.7
Peeters, M.8
-
20
-
-
42949117343
-
A sweet new role for EGFR in cancer
-
Engelman J.A., Cantley L.C. A sweet new role for EGFR in cancer. Cancer Cell 2008, 13:375-376.
-
(2008)
Cancer Cell
, vol.13
, pp. 375-376
-
-
Engelman, J.A.1
Cantley, L.C.2
-
21
-
-
57749111596
-
Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond
-
Ganapathy V., Thangaraju M., Prasad P.D. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol. Ther. 2009, 121:29-40.
-
(2009)
Pharmacol. Ther.
, vol.121
, pp. 29-40
-
-
Ganapathy, V.1
Thangaraju, M.2
Prasad, P.D.3
-
22
-
-
0034820481
-
SGLT gene expression in primary lung cancers and their metastatic lesions
-
Ishikawa N., Oguri T., Isobe T., Fujitaka K., Kohno N. SGLT gene expression in primary lung cancers and their metastatic lesions. Jpn. J. Cancer Res. 2001, 92:874-879.
-
(2001)
Jpn. J. Cancer Res.
, vol.92
, pp. 874-879
-
-
Ishikawa, N.1
Oguri, T.2
Isobe, T.3
Fujitaka, K.4
Kohno, N.5
-
23
-
-
52449085809
-
Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants
-
Kidd M., Modlin I.M., Gustafsson B.I., Drozdov I., Hauso O., Pfragner R. Luminal regulation of normal and neoplastic human EC cell serotonin release is mediated by bile salts, amines, tastants, and olfactants. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295:G260-G272.
-
(2008)
Am. J. Physiol. Gastrointest. Liver Physiol.
, vol.295
-
-
Kidd, M.1
Modlin, I.M.2
Gustafsson, B.I.3
Drozdov, I.4
Hauso, O.5
Pfragner, R.6
-
24
-
-
12944262229
-
Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer
-
Macheda M.L., Rogers S., Best J.D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell. Physiol. 2005, 202:654-662.
-
(2005)
J. Cell. Physiol.
, vol.202
, pp. 654-662
-
-
Macheda, M.L.1
Rogers, S.2
Best, J.D.3
-
25
-
-
0032530726
-
Thyroid hormone regulation of the Na+/glucose cotransporter SGLT1 in Caco-2 cells
-
Matosin-Matekalo M., Mesonero J.E., Delezay O., Poiree J.C., Ilundain A.A., Brot-Laroche E. Thyroid hormone regulation of the Na+/glucose cotransporter SGLT1 in Caco-2 cells. Biochem. J. 1998, 334(Pt 3):633-640.
-
(1998)
Biochem. J.
, vol.334
, Issue.PART 3
, pp. 633-640
-
-
Matosin-Matekalo, M.1
Mesonero, J.E.2
Delezay, O.3
Poiree, J.C.4
Ilundain, A.A.5
Brot-Laroche, E.6
-
26
-
-
42949176742
-
Survival of cancer cells is maintained by EGFR independent of its kinase activity
-
Weihua Z., Tsan R., Huang W.C., Wu Q., Chiu C.H., Fidler I.J., Hung M.C. Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 2008, 13:385-393.
-
(2008)
Cancer Cell
, vol.13
, pp. 385-393
-
-
Weihua, Z.1
Tsan, R.2
Huang, W.C.3
Wu, Q.4
Chiu, C.H.5
Fidler, I.J.6
Hung, M.C.7
-
27
-
-
79955668632
-
Regulation of Na(+)-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein
-
Leiprecht N., Munoz C., Alesutan I., Siraskar G., Sopjani M., Foller M., Stubenrauch F., Iftner T., Lang F. Regulation of Na(+)-coupled glucose carrier SGLT1 by human papillomavirus 18 E6 protein. Biochem. Biophys. Res. Commun. 2010, 4:56.
-
(2010)
Biochem. Biophys. Res. Commun.
, vol.4
, pp. 56
-
-
Leiprecht, N.1
Munoz, C.2
Alesutan, I.3
Siraskar, G.4
Sopjani, M.5
Foller, M.6
Stubenrauch, F.7
Iftner, T.8
Lang, F.9
-
28
-
-
0036559896
-
Papillomaviruses, cancer: from basic studies to clinical application
-
zur Hausen H. Papillomaviruses, cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2:342-350.
-
(2002)
Nat. Rev. Cancer
, vol.2
, pp. 342-350
-
-
zur Hausen, H.1
-
29
-
-
16244407760
-
Carcinogenicity of human papillomaviruses
-
Cogliano V., Baan R., Straif K., Grosse Y., Secretan B., El Ghissassi F. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005, 6:204.
-
(2005)
Lancet Oncol.
, vol.6
, pp. 204
-
-
Cogliano, V.1
Baan, R.2
Straif, K.3
Grosse, Y.4
Secretan, B.5
El Ghissassi, F.6
-
30
-
-
34250849300
-
The burden of HPV-related cancers
-
Chapter 2
-
Parkin D.M., Bray F. The burden of HPV-related cancers. Vaccine 2006, 24(Suppl. 3):S311-S325. Chapter 2.
-
(2006)
Vaccine
, vol.24
, Issue.SUPPL. 3
-
-
Parkin, D.M.1
Bray, F.2
-
31
-
-
78149444465
-
Stimulation of electrogenic glucose transport by glycogen synthase kinase 3
-
Rexhepaj R., Dermaku-Sopjani M., Gehring E.M., Sopjani M., Kempe D.S., Foller M., Lang F. Stimulation of electrogenic glucose transport by glycogen synthase kinase 3. Cell. Physiol. Biochem. 2010, 26:641-646.
-
(2010)
Cell. Physiol. Biochem.
, vol.26
, pp. 641-646
-
-
Rexhepaj, R.1
Dermaku-Sopjani, M.2
Gehring, E.M.3
Sopjani, M.4
Kempe, D.S.5
Foller, M.6
Lang, F.7
-
32
-
-
4644360065
-
Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB
-
Dieter M., Palmada M., Rajamanickam J., Aydin A., Busjahn A., Boehmer C., Luft F.C., Lang F. Regulation of glucose transporter SGLT1 by ubiquitin ligase Nedd4-2 and kinases SGK1, SGK3, and PKB. Obes. Res. 2004, 12:862-870.
-
(2004)
Obes. Res.
, vol.12
, pp. 862-870
-
-
Dieter, M.1
Palmada, M.2
Rajamanickam, J.3
Aydin, A.4
Busjahn, A.5
Boehmer, C.6
Luft, F.C.7
Lang, F.8
-
33
-
-
0030953469
-
Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop
-
Feng J., Witthuhn B.A., Matsuda T., Kohlhuber F., Kerr I.M., Ihle J.N. Activation of Jak2 catalytic activity requires phosphorylation of Y1007 in the kinase activation loop. Mol. Cell. Biol. 1997, 17:2497-2501.
-
(1997)
Mol. Cell. Biol.
, vol.17
, pp. 2497-2501
-
-
Feng, J.1
Witthuhn, B.A.2
Matsuda, T.3
Kohlhuber, F.4
Kerr, I.M.5
Ihle, J.N.6
-
34
-
-
78651249032
-
Functional analysis of a novel I71N mutation in the GJB2 gene among Southern Egyptians causing autosomal recessive hearing loss
-
Mohamed M.R., Alesutan I., Foller M., Sopjani M., Bress A., Baur M., Salama R.H., Bakr M.S., Mohamed M.A., Blin N., Lang F., Pfister M. Functional analysis of a novel I71N mutation in the GJB2 gene among Southern Egyptians causing autosomal recessive hearing loss. Cell. Physiol. Biochem. 2010, 26:959-966.
-
(2010)
Cell. Physiol. Biochem.
, vol.26
, pp. 959-966
-
-
Mohamed, M.R.1
Alesutan, I.2
Foller, M.3
Sopjani, M.4
Bress, A.5
Baur, M.6
Salama, R.H.7
Bakr, M.S.8
Mohamed, M.A.9
Blin, N.10
Lang, F.11
Pfister, M.12
-
35
-
-
70450240919
-
Regulation of the glutamate transporter EAAT2 by PIKfyve
-
Gehring E.M., Zurn A., Klaus F., Laufer J., Sopjani M., Lindner R., Strutz-Seebohm N., Tavare J.M., Boehmer C., Palmada M., Lang U.E., Seebohm G., Lang F. Regulation of the glutamate transporter EAAT2 by PIKfyve. Cell. Physiol. Biochem. 2009, 24:361-368.
-
(2009)
Cell. Physiol. Biochem.
, vol.24
, pp. 361-368
-
-
Gehring, E.M.1
Zurn, A.2
Klaus, F.3
Laufer, J.4
Sopjani, M.5
Lindner, R.6
Strutz-Seebohm, N.7
Tavare, J.M.8
Boehmer, C.9
Palmada, M.10
Lang, U.E.11
Seebohm, G.12
Lang, F.13
-
36
-
-
77952990809
-
The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19
-
Bohmer C., Sopjani M., Klaus F., Lindner R., Laufer J., Jeyaraj S., Lang F., Palmada M. The serum and glucocorticoid inducible kinases SGK1-3 stimulate the neutral amino acid transporter SLC6A19. Cell. Physiol. Biochem. 2010, 25:723-732.
-
(2010)
Cell. Physiol. Biochem.
, vol.25
, pp. 723-732
-
-
Bohmer, C.1
Sopjani, M.2
Klaus, F.3
Lindner, R.4
Laufer, J.5
Jeyaraj, S.6
Lang, F.7
Palmada, M.8
-
37
-
-
76249130478
-
Regulation of the glutamate transporter EAAT4 by PIKfyve
-
Alesutan I.S., Ureche O.N., Laufer J., Klaus F., Zurn A., Lindner R., Strutz-Seebohm N., Tavare J.M., Boehmer C., Palmada M., Lang U.E., Seebohm G., Lang F. Regulation of the glutamate transporter EAAT4 by PIKfyve. Cell. Physiol. Biochem. 2010, 25:187-194.
-
(2010)
Cell. Physiol. Biochem.
, vol.25
, pp. 187-194
-
-
Alesutan, I.S.1
Ureche, O.N.2
Laufer, J.3
Klaus, F.4
Zurn, A.5
Lindner, R.6
Strutz-Seebohm, N.7
Tavare, J.M.8
Boehmer, C.9
Palmada, M.10
Lang, U.E.11
Seebohm, G.12
Lang, F.13
-
38
-
-
0036354858
-
Expression of glucose transporter-1 in cervical cancer and its precursors
-
Mendez L.E., Manci N., Cantuaria G., Gomez-Marin O., Penalver M., Braunschweiger P., Nadji M. Expression of glucose transporter-1 in cervical cancer and its precursors. Gynecol. Oncol. 2002, 86:138-143.
-
(2002)
Gynecol. Oncol.
, vol.86
, pp. 138-143
-
-
Mendez, L.E.1
Manci, N.2
Cantuaria, G.3
Gomez-Marin, O.4
Penalver, M.5
Braunschweiger, P.6
Nadji, M.7
-
39
-
-
0242332098
-
GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer
-
Rudlowski C., Becker A.J., Schroder W., Rath W., Buttner R., Moser M. GLUT1 messenger RNA and protein induction relates to the malignant transformation of cervical cancer. Am. J. Clin. Pathol. 2003, 120:691-698.
-
(2003)
Am. J. Clin. Pathol.
, vol.120
, pp. 691-698
-
-
Rudlowski, C.1
Becker, A.J.2
Schroder, W.3
Rath, W.4
Buttner, R.5
Moser, M.6
-
40
-
-
0031917467
-
Functional significance of cell volume regulatory mechanisms
-
Lang F., Busch G.L., Ritter M., Volkl H., Waldegger S., Gulbins E., Haussinger D. Functional significance of cell volume regulatory mechanisms. Physiol. Rev. 1998, 78:247-306.
-
(1998)
Physiol. Rev.
, vol.78
, pp. 247-306
-
-
Lang, F.1
Busch, G.L.2
Ritter, M.3
Volkl, H.4
Waldegger, S.5
Gulbins, E.6
Haussinger, D.7
-
41
-
-
15844414581
-
Regulation of Na+/glucose cotransporter expression by protein kinases in Xenopus laevis oocytes
-
Hirsch J.R., Loo D.D., Wright E.M. Regulation of Na+/glucose cotransporter expression by protein kinases in Xenopus laevis oocytes. J. Biol. Chem. 1996, 271:14740-14746.
-
(1996)
J. Biol. Chem.
, vol.271
, pp. 14740-14746
-
-
Hirsch, J.R.1
Loo, D.D.2
Wright, E.M.3
-
42
-
-
62649114642
-
Protein kinase-A affects sorting and conformation of the sodium-dependent glucose co-transporter SGLT1
-
Subramanian S., Glitz P., Kipp H., Kinne R.K., Castaneda F. Protein kinase-A affects sorting and conformation of the sodium-dependent glucose co-transporter SGLT1. J. Cell. Biochem. 2009, 106:444-452.
-
(2009)
J. Cell. Biochem.
, vol.106
, pp. 444-452
-
-
Subramanian, S.1
Glitz, P.2
Kipp, H.3
Kinne, R.K.4
Castaneda, F.5
-
43
-
-
77950195325
-
Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase
-
Sopjani M., Bhavsar S.K., Fraser S., Kemp B.E., Foller M., Lang F. Regulation of Na+-coupled glucose carrier SGLT1 by AMP-activated protein kinase. Mol. Membr. Biol. 2010, 27:137-144.
-
(2010)
Mol. Membr. Biol.
, vol.27
, pp. 137-144
-
-
Sopjani, M.1
Bhavsar, S.K.2
Fraser, S.3
Kemp, B.E.4
Foller, M.5
Lang, F.6
|